
The product is not in stock
Myxohemovirovac
Vaccine against myxomatosis and viral hemorrhage
Composition: Mixo component (live, lyophilized rabbit myxomatosis vaccine prepared with MXO-82 loading) 103 TCID50 (dose to infect 50% of tissue culture) minimum dose titer; Haemo component inactivated aqueous vaccine against viral hemorrhagic diseases of rabbits prepared with VSHI-CN-6 load) minimum titer 1024 unit dose before inactivation;
Indications for use: the vaccine is used for the prevention and control of myxomatosis and viral hemorrhagic diseases.
Release form: in vials of 10 doses.
Country of Manufacture: S.C. Romvac Company S.A. Romania